Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback